Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antibody Drug Conjugates (ADCs). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115109118A introduces a solid-phase synthesis method for DS-8201 intermediates, offering superior purity and cost reduction for ADC manufacturing.